| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
82,625,000 |
| Market
Cap: |
187.56(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.59 - $8.14 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of immunotherapies to treat cancer. Co. in-licensed its lead immuno-oncology product candidate, toripalimab (CHS-007), an anti-PD-1 antibody, from Shanghai Junshi Biosciences Co., Ltd. Toripalimab is being evaluated in late-stage clinical trials for the treatment of a range of tumor types. Co.'s commercial portfolio includes two U.S. Food and Drug Administration-approved biologics, including UDENYCA® (pegfilgrastim-cbqv), a biosimilar to Neulasta®, a granulocyte-colony stimulating factor and YUSIMRY™ (adalimumab-aqvh), its Humira® (adalimumab) biosimilar product.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
223,100 |
223,100 |
223,100 |
| Total Sell Value |
$0 |
$449,770 |
$449,770 |
$449,770 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
1 |
1 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-12-03 |
4 |
S |
$18.67 |
$929,079 |
D/D |
(49,756) |
32,569 |
|
23% |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-12-03 |
4 |
OE |
$17.17 |
$861,602 |
D/D |
49,756 |
82,325 |
|
- |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-11-18 |
4 |
AS |
$18.00 |
$77,094 |
D/D |
(4,283) |
32,569 |
|
-18% |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-11-18 |
4 |
OE |
$12.70 |
$54,394 |
D/D |
4,283 |
36,852 |
|
- |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-11-17 |
4 |
AS |
$17.50 |
$326,416 |
D/D |
(18,487) |
32,569 |
|
-19% |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-11-17 |
4 |
OE |
$2.50 |
$6,251 |
D/D |
2,500 |
51,056 |
|
- |
|
| Viret Jean-Frederic |
Chief Financial Officer |
• – – |
2020-11-17 |
4 |
OE |
$13.50 |
$20,250 |
D/D |
1,500 |
40,269 |
|
- |
|
| Viret Jean-Frederic |
Chief Financial Officer |
• – – |
2020-11-17 |
4 |
AS |
$17.49 |
$34,896 |
D/D |
(1,995) |
38,769 |
|
-19% |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-10-19 |
4 |
AS |
$17.89 |
$57,556 |
D/D |
(3,217) |
48,556 |
|
-6% |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-10-19 |
4 |
OE |
$2.50 |
$15,357 |
D/D |
3,217 |
51,773 |
|
- |
|
| Viret Jean-Frederic |
Chief Financial Officer |
• – – |
2020-10-14 |
4 |
AS |
$19.00 |
$116,736 |
D/D |
(6,144) |
40,423 |
|
-11% |
|
| Healy James |
Director |
– • – |
2020-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
213,546 |
434,555 |
|
- |
|
| Healy James |
Director |
– • – |
2020-09-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(950,000) |
0 |
|
- |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-09-17 |
4 |
AS |
$18.84 |
$94,216 |
D/D |
(5,000) |
48,556 |
|
-1% |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-09-17 |
4 |
OE |
$2.50 |
$38,001 |
D/D |
5,000 |
53,556 |
|
- |
|
| Healy James |
Director |
– • – |
2020-08-28 |
4 |
A |
$0.00 |
$0 |
I/I |
221,009 |
221,009 |
|
- |
|
| Healy James |
Director |
– • – |
2020-08-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(983,221) |
950,000 |
|
- |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-08-17 |
4 |
AS |
$19.37 |
$96,851 |
D/D |
(5,000) |
48,556 |
|
-13% |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-08-17 |
4 |
OE |
$2.50 |
$38,001 |
D/D |
5,000 |
53,556 |
|
- |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-07-17 |
4 |
AS |
$18.25 |
$273,687 |
D/D |
(15,000) |
48,556 |
|
1% |
|
| Anicetti Vincent R |
Chief Operating Officer |
• – – |
2020-07-17 |
4 |
OE |
$2.50 |
$165,001 |
D/D |
15,000 |
63,556 |
|
- |
|
| Lanfear Dennis M |
President & CEO |
• • – |
2020-07-01 |
4 |
OE |
$0.01 |
$249 |
D/D |
29,994 |
193,258 |
|
- |
|
| Szela Mary T |
Director |
– • – |
2020-06-22 |
4 |
S |
$17.58 |
$966,759 |
D/D |
(54,997) |
0 |
|
6% |
|
| Szela Mary T |
Director |
– • – |
2020-06-22 |
4 |
OE |
$2.50 |
$485,900 |
D/D |
54,997 |
54,997 |
|
- |
|
| Wahlstrom Mats |
Director |
– • – |
2020-06-17 |
4 |
S |
$17.15 |
$3,430,020 |
I/I |
(200,000) |
0 |
|
-0% |
|
312 Records found
|
|
Page 4 of 13 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.10 (4.61%) 
